Patents Assigned to Baxter International Inc.
-
Patent number: 11278510Abstract: The present disclosure relates to a sterile medical product for parenteral nutrition comprising a polymeric container having at least a first and a second chamber which are separated by a non-permanent peel seal, wherein the first chamber contains a composition of amino acids and optionally electrolytes, and wherein the second chamber contains a dextrose solution, and wherein the product is characterized by a high protein (nitrogen) content per volume. The reconstituted solution is configured to be administered peripherally or centrally for the treatment of patients suffering from malnutrition and/or having a need for increased uptake of amino acids.Type: GrantFiled: September 5, 2019Date of Patent: March 22, 2022Assignees: Baxter International Inc., Baxter Healthcare SAInventors: Vanja Pinoie, Preeti Sharma, Julianna Roth Jakubowski, Mary Hise Brown
-
Patent number: 11273245Abstract: A system for performing a dialysis treatment includes a dialysis fluid machine; a disposable dialysis fluid carrying member operable with the dialysis fluid machine; and a venting filter provided by the disposable member, the venting filter positioned and arranged to be coupled along with the disposable member to the dialysis fluid machine to perform the dialysis treatment and to vent air from the disposable member.Type: GrantFiled: December 17, 2019Date of Patent: March 15, 2022Assignees: Baxter International Inc., Baxter Healthcare SAInventors: Robert W. Childers, Richard Avoy, John Booras, Joseph H. Bowman, Paul Grippo, Andrew D. Hopping, David Howard, Jeffrey W. Jerrell, Benjamin Kellam, Brian Lauman, Sherwin Shang, David Vescovi, Tahua Yang, Alex Yu
-
Patent number: 11260153Abstract: A renal therapy system is disclosed. In an example, a renal therapy system includes a dialysis fluid pump, a control processor for controlling a treatment performed by the dialysis fluid pump, and a user interface device in operable communication with the control processor.Type: GrantFiled: June 3, 2019Date of Patent: March 1, 2022Assignees: Baxter International Inc., Baxter Healthcare SAInventors: Neil Tiwari, Joshua James Miller, Marc Steven Minkus, Matthew R. Muller, Derek Wiebenson, Douglas L. Wilkerson, Timothy G. Robinson, Anders J. Wellings, Kathryn Louise Hansbro, Borut Cizman, Brian S. Kunzeman, Robin D. Cooper, Timothy L. Kudelka, Angelo A. Sarto, Steve Joseph Lindo, Jostein Baustad, Duston Mounts, Shafali Hill
-
Patent number: 11255860Abstract: A method of quantifying the amount of glucose in a sample is provided herein that may further comprise an interferent such as mannitol. At least two measurements are obtained using measurement methods that differ in their sensitivity to the amount of interferent in the sample, thus enabling the results to be compared to determine whether any interferent is present in the sample. A glucose sensor for carrying out a method described herein is also provided.Type: GrantFiled: January 26, 2018Date of Patent: February 22, 2022Assignees: Baxter International Inc., Baxter Healthcare SAInventors: Barry Colin Crane, William Paul Paterson, Nicholas Paul Barwell, Peter Edgley
-
Patent number: 11253849Abstract: Methods, sorbent cartridges and cleaning devices are disclosed for refurbishing sorbent materials. In one implementation among multiple implementations, a medical fluid delivery method includes: providing a sorbent cartridge including H+ZP within a casing for a treatment; and after the treatment, refurbishing the H+ZP while maintained within the casing via (i) regenerating the non-disinfected H+ZP by flowing an acid solution through the casing, (ii) rinsing the regenerated H+ZP while maintained within the casing, (iii) disinfecting the regenerated and rinsed H+ZP by flowing a disinfecting agent through the casing, and (iv) rinsing the regenerated and disinfected H+ZP while maintained within the casing. Multiple batch sorbent refurbishing implementations are also disclosed.Type: GrantFiled: November 28, 2018Date of Patent: February 22, 2022Assignees: Baxter International Inc., Baxter Healthcare SAInventors: Yuanpang Samuel Ding, Rosa Hung-Chen Yeh, Cristian Adolfo Menzel Bueno, Ieng Kin Lao
-
Patent number: 11255795Abstract: A drip chamber for an infusion tube that includes a first end arranged to receive a drip tube, a second end including an exit port, at least one wall connecting the first and second ends, a space enclosed by the first and second ends and the at least one wall, and first and second lenses each directly fixed to said at least one wall.Type: GrantFiled: August 26, 2019Date of Patent: February 22, 2022Assignees: BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE SAInventors: Peter Hammond, James F. Munro, Luke Postema, Tuan Bui
-
Patent number: 11247035Abstract: A cleaning device for disinfecting a Luer access device includes a housing and a cleaning material. The housing has an opening and elastomeric sidewalls defining an inner cavity. The elastomeric sidewalls are configured to deform and conform to respective surface features of the Luer access device. The cleaning material is positioned within the inner cavity and carries a disinfectant. The cleaning device is configured to removably engage the Luer access device, and the cleaning material is configured to contact at least a portion of the Luer access device when the cleaning device is engaged with the Luer access device.Type: GrantFiled: May 13, 2019Date of Patent: February 15, 2022Assignees: Baxter International Inc., Baxter Healthcare SAInventors: Thomas Edward Dudar, Kent Lane Lurvey, Jeffrey Clyde Nichols, Michael Tung Kiung Ling, Donald Smith, Mark Louis Thoene, Brian Young, David Andrew Ippolito
-
Patent number: 11246938Abstract: Provided herein are hemostatic compositions. In one embodiment, the hemostatic composition includes cross-linked polymer microspheres, such as cross-linked gelatin microspheres with pores. In another embodiment, the hemostatic composition comprises an additive such as a wetting agent, a suspending agent, or both. The hemostatic compositions may also include a hemostatic agent such as thrombin, and may include a high concentration of thrombin. The hemostatic compositions may also include plasma. Also provided herein are devices for dispersing said hemostatic compositions in a diluent, and delivering said dispersed hemostatic composition. The hemostatic compositions may also fabricated with a selected geometry as administration suggests.Type: GrantFiled: March 4, 2019Date of Patent: February 15, 2022Assignee: Baxter International Inc.Inventors: Richard I. Senderoff, Jeffrey D. Meyer, Emily N. Rollins, Steven D. Hughes, Richard M. Garcia, Paul D. Bishop, Gerald W. Lasser
-
Patent number: 11235094Abstract: A system for dialysis is disclosed. An example peritoneal dialysis system includes a peritoneal dialysis machine including a pumping mechanism, and a sensor configured to measure a property of peritoneal dialysis fluid. The peritoneal dialysis system also includes a disposable cassette operable with the peritoneal dialysis machine. The disposable cassette includes a fluid source inlet for accepting fluid from a fluid source and a fluid flow path in fluid communication with the fluid source inlet. The fluid flow path includes a pump chamber operable with the pumping mechanism to pump fluid through the fluid flow path. The disposable cassette also includes a concentrate inlet for fluidly communicating concentrate to the fluid flow path, and a sensor chamber located along the fluid flow path and operable with the sensor. The sensor is configured to provide feedback to the peritoneal dialysis machine for mixing the concentrate for forming peritoneal dialysis fluid.Type: GrantFiled: July 29, 2019Date of Patent: February 1, 2022Assignees: Baxter International Inc.Inventors: Robert W. Childers, David S. Brown, Ramesh Wariar, Sujatha Karoor, Shahid Din, Leo Martis, Cody Buchmann, Paul Soltys
-
Patent number: 11229405Abstract: The invention provides a neck-worn sensor that is a single, body-worn system that measures the following parameters from an ambulatory patient: heart rate, pulse rate, pulse oximetry, respiratory rate, temperature, thoracic fluid levels, stroke volume, cardiac output, and a parameter sensitive to blood pressure called pulse transit time. From stroke volume, a first algorithm employing a linear model can estimate the patient's pulse pressure. And from pulse pressure and pulse transit time, a second algorithm, also employing a linear algorithm, can estimate systolic blood pressure and diastolic blood pressure. Thus, the sensor can measure all five vital signs along with hemodynamic parameters. It also includes a motion-detecting accelerometer, from which it can determine motion-related parameters such as posture, degree of motion, activity level, respiratory-induced heaving of the chest, and falls.Type: GrantFiled: December 18, 2015Date of Patent: January 25, 2022Assignees: BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE SAInventors: Matthew Banet, Marshal Singh Dhillon, Susan Meeks Pede, Kenneth Robert Hunt
-
Patent number: 11224683Abstract: A method of performing dialysis includes: recirculating a dialysis fluid from a patient or a dialyzer for at least two cycles, each cycle contacting the dialysis fluid first with a zirconium phosphate layer followed by at least one of a urease layer, a zirconium oxide layer, or a carbon layer; storing the recirculated dialysis fluid in a storage container; and transferring the dialysis fluid from the storage container to the patient or the dialyzer. In one example, the zirconium phosphate layer and the at least one of the urease layer, the zirconium oxide layer, or the carbon layer is provided by a sorbent cartridge.Type: GrantFiled: October 23, 2019Date of Patent: January 18, 2022Assignees: Baxter International Inc., Baxter Healthcare SAInventor: Sujatha Karoor
-
Patent number: 11207453Abstract: A peritoneal dialysis catheter includes: a catheter tube defining a lumen for carrying peritoneal dialysis fluid to at least one aperture located at or near a distal end of the lumen; at least one cuff located along the outside of the catheter tube; an access site proximally spaced from the at least one cuff, the access site allowing an antimicrobial agent to be introduced into the catheter tube; a reservoir operable with the catheter tube and in fluid communication with the access site, the reservoir storing an amount of the antimicrobial agent received from the access site after an antimicrobial agent introducer is removed from the access site; and a delivery area of the catheter tube in fluid communication with the reservoir, the delivery area positioned so as to target delivery of the antimicrobial agent to the at least one cuff or other desired location along the catheter tube.Type: GrantFiled: May 24, 2019Date of Patent: December 28, 2021Assignees: Baxter International Inc., Baxter Healthcare SAInventor: Mark Perry
-
Patent number: 11202848Abstract: Compositions and methods for sealing tissue of a patient in a wet environment are disclosed.Type: GrantFiled: March 7, 2018Date of Patent: December 21, 2021Assignees: Baxter International Inc., Baxter Healthcare SAInventors: Yves A. Delmotte, Jonathan Payssan
-
Patent number: 11179516Abstract: A medical fluid delivery machine includes a pump interface having an actuation area for delivering positive or negative pressure to a medical fluid handling device; a pressure sensor positioned to measure pressure within the actuation area; a valve positioned to selectively vent the actuation area to atmosphere; and a control unit in signal communication with the pressure sensor and control communication with the valve, the control unit performing a sequence during pumping, wherein (i) application of positive pressure or negative pressure to the actuation area is stopped, the valve is switched to vent the actuation area to atmosphere, then switched to close the actuation area to atmosphere, and at least one pressure signal reading is taken via the pressure sensor, and (ii) a determination is made whether positive pressure or negative pressure to the chamber should be resumed based on the at least one pressure signal reading.Type: GrantFiled: June 22, 2017Date of Patent: November 23, 2021Assignees: Baxter International Inc., Baxter Healthcare SAInventors: Yuanpang Ding, Ryan Joseph Thomas, Anders John Wellings, James Anthony Sloand
-
Patent number: 11177026Abstract: A medical device data back-association system, apparatuses, and methods are disclosed. In an example embodiment, a server receives first medical device data from a medical device including a device identifier and stores the first medical device data to an unassociated record in a database after determining that there is no association between the device identifier and any patient identifier or medication order identifier. While the medical device is administering the medication to a patient, the server receives an identifier message including at least two of the device identifier, the patient identifier, and the medication order identifier. The server creates an identifier association between a medical record of the patient and the medical device using the identifier message. The server uses the identifier association to store subsequent medical device data from the medical device to the medical record of the patient.Type: GrantFiled: May 10, 2019Date of Patent: November 16, 2021Assignees: Baxter International Inc., Baxter Healthcare SAInventors: Troy David Heavelyn, Curt Matthew Allen, Phillip Edwin Fisk
-
Patent number: 11173189Abstract: In an aspect, a method of manufacture of a pharmaceutically acceptable solid composition containing daptomycin includes drying an aqueous solution containing (i) water, (ii) the daptomycin, (iii) sorbitol in an amount of about 1.2 wt. % to about 9.0 wt. % of total volume of the aqueous composition and (iv) mannitol in an amount of about 0.6 wt. % to about 9.5 wt. % of total volume of the aqueous composition to form the solid composition. The drying can include an sublimation drying of about ?25° C. to about 50° C. for a time period of about 15 hours to about 120 hours, most preferably about 15° C. for about 20 hours, optionally preceded and/or followed by one or more additional drying steps. Other aspects are the solid composition containing the daptomycin and also methods of treating a bacterial infection including administering a pharmaceutically acceptable product made by reconstituting the solid composition.Type: GrantFiled: March 11, 2021Date of Patent: November 16, 2021Assignees: Baxter International Inc., Baxter Healthcare SAInventors: Lindsay Wegiel, Reagan Miller
-
Patent number: 11170883Abstract: A peritoneal dialysis system includes (i) a fill container, and (ii) an energizing unit that removably accepts the fill container, the energizing unit including a sterilization source so configured and arranged relative to the fill container when accepted by the energizing unit to place fluid within the fill container in a physiologically safe condition for delivery to the peritoneal cavity of a patient.Type: GrantFiled: March 11, 2014Date of Patent: November 9, 2021Assignees: Baxter International Inc., Baxter Healthcare SAInventor: Marc Steven Minkus
-
Patent number: 11141072Abstract: The invention provides a neck-worn sensor (referred to herein as the ‘necklace’) that is a single, body-worn system that measures the following parameters from an ambulatory patient: heart rate, pulse rate, pulse oximetry, respiratory rate, temperature, thoracic fluid levels, stroke volume, cardiac output, and a parameter sensitive to blood pressure called pulse transit time. From stroke volume, a first algorithm employing a linear model can estimate the patient's pulse pressure. And from pulse pressure and pulse transit time, a second algorithm, also employing a linear algorithm, can estimate systolic blood pressure and diastolic blood pressure. Thus, the necklace can measure all five vital signs along with hemodynamic parameters. It also includes a motion-detecting accelerometer, from which it can determine motion-related parameters such as posture, degree of motion, activity level, respiratory-induced heaving of the chest, and falls.Type: GrantFiled: June 10, 2019Date of Patent: October 12, 2021Assignees: BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE SAInventors: Matthew Banet, Susan Meeks Pede, Marshal Singh Dhillon, Andrew Terry, Kenneth Robert Hunt
-
Patent number: 11135344Abstract: A dialysis system for determining an amount of total chlorine in a partially purified water sample is disclosed. The system includes a water machine that produces at least partially purified water including an at least partially purified water sample and a dialysis machine that provides a dialysis treatment to a patient. The dialysis machine receives the at least partially purified water from the water machine to prepare dialysis fluid for the dialysis treatment. The system also includes a total chlorine detector configured to receive the at least partially purified water sample, at a first time apply a source voltage to the at least partially purified water sample, and at a second time stop applying the source voltage to the at least partially purified water sample and instead monitor a sensed electrical parameter to determine an amount of total chlorine in the at least partially purified water sample.Type: GrantFiled: August 13, 2018Date of Patent: October 5, 2021Assignees: Baxter International Inc., Baxter Healthcare SAInventors: Jeff White, Ye Chen, Yuanpang Samuel Ding, Joel Titus, Justin Rohde, Shincy Maliekkal, Kevin Cooper
-
Patent number: 11129537Abstract: The invention provides a sensor for measuring both impedance and ECG waveforms that is configured to be worn around a patient's neck. The sensor features 1) an ECG system that includes an analog ECG circuit, in electrical contact with at least two ECG electrodes, that generates an analog ECG waveform; and 2) an impedance system that includes an analog impedance circuit, in electrical contact with at least two (and typically four) impedance electrodes, that generates an analog impedance waveform. Also included in the neck-worn system are a digital processing system featuring a microprocessor, and an analog-to-digital converter. During a measurement, the digital processing system receives and processes the analog ECG and impedance waveforms to measure physiological information from the patient. Finally, a cable that drapes around the patient's neck connects the ECG system, impedance system, and digital processing system.Type: GrantFiled: September 30, 2019Date of Patent: September 28, 2021Assignees: BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE SAInventors: Matthew Banet, Susan Meeks Pede, Marshal Singh Dhillon, Kenneth Robert Hunt